QIAGEN

We are proud that our therascreen KRAS RGQ PCR Kit has been approved by the FDA as a companion diagnostic for KRAZATI® (adagrasib) in combination with cetuximab for colorectal cancer. This approval allows healthcare professionals to identify colorectal cancer (CRC) patients with the KRAS mutation – helping ensure they receive the most effective, targeted therapies. The therascreen KRAS RGQ PCR Kit ✅ Detects actionable alterations in the KRAS gene that are predictive of drug response with high sensitivity and specificity ✅ Simplifies the diagnostic process for faster, informed treatment decisions ✅ Helps connect colorectal cancer patients with treatments tailored to their specific needs This milestone highlights our dedication to advancing precision medicine and making a real difference in patient outcomes.

✅ Explore the benefits of combining broad NGS detection with targeted dPCR validation to double your impact for monitoring biomarkers. Learn more here 👉 https://lnkd.in/eCs38yid

🎉 We’re excited to announce U.S. clearance for the QIAstat-Dx Gastrointestinal Panel 2 Mini B&V, tailored to provide rapid answers for outpatient diagnosis of gastrointestinal conditions. Learn more 👉 https://lnkd.in/ezUjEmFd ✅ The new panel detects five common bacterial and viral pathogens causing gastrointestinal infections to support year-round outpatient care with fast and accurate results. ✅ We are the first to offer both comprehensive and targeted syndromic gastrointestinal panels, giving clinicians unmatched flexibility to optimize diagnostics for individual patients. 🚀 The QIAstat-Dx Rise, a higher-capacity instrument version, will be submitted for U.S. regulatory clearance in early 2025, following the success of four QIAstat-Dx Panel clearances in 2024.

If you want to make your lab work more productive and cost-efficient, we have good news for you! QIAcuity dPCR now supports high-order multiplexing capabilities without requiring instrument hardware changes, enabling deeper insights from biological samples. Learn more 👉 https://lnkd.in/eUS973DC ✅ Detect up to 12 targets simultaneously from a single biological sample – a more than two-fold increase from the previous limit of five targets. ✅ The new QIAcuity Software 3.1 update and the QIAcuity High Multiplex Probe PCR Kit enable this capability with no hardware changes required. ✅ Save time, reduce reagent consumption, and optimize the use of precious sample materials for more productive and cost-efficient lab work.

🎉 We are proud to support the British National Health Service (NHS) and Genomics England with our Clinical Knowledge Base to power a first-of-its-kind whole-genome sequencing study for newborns. Learn more 👉 https://lnkd.in/eZrjK5E8 ✅ This initiative aims to sequence the genomes of 100,000 newborns in the United Kingdom (UK) to screen for over 200 selected conditions, enabling earlier diagnosis and treatment. ✅ Our clinically relevant variant content will be available at testing sites across the UK to support evidence-based variant interpretation and result reporting. ✅ Partnering with Genomics England in this landmark program allows us to provide nationwide access to the power of whole-genome sequencing for newborns in the UK, with the potential to improve the health of thousands of families.

🙌 We're proud to announce that QIAGEN has once again achieved a perfect 💯 in the Human Rights Campaign Foundation’s 2025 Corporate Equality Index (CEI)! 🌍 This recognition underscores our unwavering commitment to fostering an inclusive workplace where LGBTQ+ equality thrives. The CEI primarily evaluates U.S. companies on comprehensive non-discrimination policies, equitable benefits, inclusive culture initiatives, and public commitment to LGBTQ+ equality. 👏 A huge thank you to all QIAGENers—across every level and role—for creating a workplace where everyone feels valued, respected, and empowered to succeed. Together, we’re building a better future for all.

🙏 As we reflect on 2024, we want to take a moment to extend our heartfelt gratitude to everyone who has been part of our journey – our dedicated employees, loyal customers, and amazing partners. 🌟 Your passion and commitment have been the driving force behind our mission to make improvements in life possible in a year filled with challenges and opportunities alike. 🎉 Here’s to celebrating your unwavering support and partnership. We wish you a wonderful holiday season and a bright, successful New Year ahead!

🌍 Taking action on renewable energy isn’t just about numbers—it’s about making a tangible difference for the environment and future generations. ✅ At QIAGEN, we’ve made progress by transitioning to renewable energy at our Germantown and Hilden sites, contributing to 84% green electricity across all our locations—and this is just the beginning! ✅ Looking ahead to 2025, we will continue our green electricity sourcing strategy while focusing on energy efficiency gains to maximize our impact. This is part of our commitment to achieving our goal of a validated net-zero carbon footprint by 2050. 💡 Want to learn more about sustainability at QIAGEN? Check out our new sustainability webpage, where we share all the details about our ongoing efforts to protect the planet. 👉 https://lnkd.in/eGuzese

We are excited to announce the launch of our Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Learn more 👉 https://lnkd.in/eW3b5rAb ✅ Our Ingenuity Pathway Analysis Interpret extends the analysis capabilities of a human-curated knowledge base with AI technology. ✅ This AI extension highlights key biological elements at work and provides summarized results and interpretations in a shareable web document, speeding up the interpretation process. ✅ Ingenuity Pathway Analysis Interpret is the key to unlocking the full potential of biological data by streamlining the interpretation process and delivering actionable insights for experiments.

Get great results while lessen pipetting, lower energy usage and increase efficiency 🧪. Join now and in 20 minutes: ✅ Unbox the leaner, greener QIAwave kit. Get more out of #DNA and #RNA isolations while taking out the trash less often. ✅ Reduce RNA-seq pipetting by >80%. Stop pipetting box after box of filter tips. Get the same diversity of results with 11 fewer boxes of filter tips per 192 reactions. ✅ Save space in your –20? Learn tricks and tips on how you can reduce your cold storage and lab's energy use.